A clinical trial at the University of Calgary is testing whether high doses of vitamin B3, known as niacin, can improve outcomes for patients with glioblastoma, one of the most aggressive forms of brain cancer.
Early interim results from the ongoing Phase I/II study published June 22, 2026 in the Journal of Neuro-Oncology showed that 82% of participants had no disease progression at six months, compared with a historical benchmark of 64% from prior studies, according to researchers.
Read Full Article: https://www.naturalnews.com/2026-06-26-niacin-shows-promise-against-aggressive-brain-cancer.html
